Anxiety and obsessive-compulsive symptoms in adolescents often evolve quickly and can become difficult to manage despite appropriate psychiatric care. While pharmacologic treatment remains an important component of care, some patients continue to experience persistent distress, emotional dysregulation, and functional impairment despite medication adjustments.

This case highlights the clinical journey of an 18-year-old college student whose worsening anxiety and OCD symptoms showed a rapid and notable shift following a functional psychiatry approach — including targeted nutritional support and low-dose lithium orotate.

Patient Background

Amanda, an 18-year-old female college student living away from home, presented with escalating anxiety symptoms during her first year in a college hostel environment. Her lifestyle included:

• Irregular eating habits (frequent skipped breakfasts)
• Academic and social stressors
• Limited family support due to distance from home

Past history included:

• Anxiety during adolescence (primarily exam-related)
• Polycystic ovarian disease (PCOS) diagnosed in 2024
• Prior mild thyroid dysregulation

Initial Presentation

October 10, 2025

Amanda presented to her college medical center requesting psychiatric evaluation after experiencing an acute anxiety episode. She was hospitalized briefly and discharged with a diagnosis of anxiety attack and prescribed:

• Paroxetine
• Clonazepam (0.5 mg)

Soon afterward, her parents learned Amanda was experiencing excessive guilt, disproportionate worry, and escalating emotional distress. A concerning message written days earlier suggested significant psychological suffering.

Escalation of Symptoms and Treatment Changes

Over the following three months, the patient received care from multiple providers.

Psychiatric Course (Oct 2025 – Jan 2026)

Diagnosis evolved sequentially:

• Situational Anxiety
• Generalized Anxiety Disorder
• Moderate–Severe OCD (Y-BOCS confirmed)

Medication adjustments included:

• Sertraline titrated to 100 mg daily
• Buspirone added
• Clonazepam prescribed as needed
• Transcranial Magnetic Stimulation (TMS) suggested

Despite escalating treatment:

• Anxiety persisted
• Intrusive thoughts intensified
• Emotionally disturbing vivid dreams developed
• Reassurance-seeking behaviors increased
• Patient reported feeling unheard and without relief

College authorities eventually advised relocation from the hostel due to psychological instability and campus safety concerns.

Functional Medicine Evaluation

In February 2026, a functional assessment was initiated. The key findings:

Genetics & Nutrients

• MTHFR variant: CT
• Vitamin B12: 500 pg/mL (functional insufficiency possible)
• Vitamin D: 37 ng/mL
• Vitamin C: Low (3.5 mg/L)

Biochemical Markers

• Homocysteine: 9.2
• Blunted morning cortisol with elevated evening cortisol
• Low omega-3 fatty acids
• High-normal serum copper with unclear copper–zinc balance

Additional Testing

• OAT and stool analysis pending at time of reporting

These findings suggested potential contributors to neuropsychiatric vulnerability including methylation stress, micronutrient insufficiency, circadian dysregulation, and metabolic imbalance.

Functional Psychiatry Intervention

After completing Psychiatry Redefined training modules, the treating physician introduced targeted nutritional interventions.

Initiated February 9–10, 2026

Nutritional Support

• Methylcobalamin 1500 mcg (sublingual, BID)
• L-methylfolate 1 mg BID
• P5P (Vitamin B6) 50 mg daily
• Vitamin D3 4000 IU with K2 and magnesium

Neuroregulatory Support

• Lithium orotate 5 mg on alternate days (The only available formulation locally.)

Clinical Response

Within 3 days a marked shift was observed:

• Reduced emotional reactivity
• Improved mood stability
• Decrease in intrusive thoughts
• Reduced anxiety intensity
• No longer seeking clonazepam reassurance
• Patient reported feeling “calm” and satisfied with emotional state

Notably, improvement appeared temporally associated with initiation of low-dose lithium support.

By mid-February:

• Patient described feeling happy and emotionally stable
• Intrusive thoughts significantly diminished
• Benzodiazepine use declined spontaneously

Ongoing Plan

Current goals include:

• Gradual taper of sertraline
• Possible discontinuation of buspirone
• Continued nutritional and metabolic optimization
• Awaited interpretation of OAT and stool testing

Clinical Discussion

This case illustrates several themes increasingly recognized in functional psychiatry:

1. Symptom Progression May Reflect Biological Vulnerability

Despite appropriate psychiatric care, underlying metabolic and nutritional contributors may perpetuate symptoms.

2. Microdose Lithium as a Neuroregulatory Adjunct

Low-dose lithium may support:

• Emotional regulation
• Neurotransmitter balance
• Stress resilience
• Reduction in intrusive cognition

Even at nutritional doses, lithium may influence neurobiological stability in susceptible individuals.

3. Importance of Personalized Medicine

Rather than replacing psychiatric care, functional interventions complemented ongoing treatment and appeared to improve overall response.

Clinical Reflection

The treating physician notes:

“For the first time in my medical career, psychiatry began to make deeper sense through a functional medicine lens. Addressing biological individuality transformed how I understood Amanda’s recovery.”

Key Takeaways for Clinicians

• Persistent anxiety or OCD symptoms may warrant metabolic and nutritional investigation.
• Functional psychiatry approaches can complement conventional psychiatric care.
• Low-dose lithium deserves thoughtful clinical exploration as a neuroregulatory support — with appropriate monitoring and clinical judgment.
• Rapid clinical change may occur when underlying vulnerabilities are addressed.

Disclaimer
This case represents a single clinical experience and is shared for educational purposes. Individual responses vary, and treatment decisions should always be personalized and medically supervised.